Trevena Announces TRV027 Selected by NIH-Funded ACTIV Initiative For COVID-19 Trial May 06, 2021 7:03am EDT
Trevena, Inc. to Participate at the Sachs Associates 4th Annual Neuroscience Innovation Forum Apr 29, 2021 7:00am EDT
Trevena Announces TRV027 Selected for Study in Global REMAP-CAP Trial in COVID-19 Patients Apr 21, 2021 7:00am EDT
Trevena, Inc. Announces Presentations of OLINVYK™ Health Economic Models at AMCP 2021 Annual Meeting Apr 15, 2021 7:30am EDT
Trevena to Release Fourth Quarter and Full Year 2020 Financial Results on March 9, 2021 Mar 05, 2021 7:00am EST
